Shaping of cutaneous function by encounters with commensals

Journal of Physiology

Volumn 595, Issue 2, 2017, Pages 437-450

  Barnard, Emma ^a   Li, Huiying ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIOPHAGE; COMMENSAL; COMMENSALISM; HUMAN; MALASSEZIA; METAGENOME; METATRANSCRIPTOMICS; MICROBIAL ACTIVITY; MOLECULAR INTERACTION; NONHUMAN; PRIORITY JOURNAL; PROPIONIBACTERIUM ACNES; PROTEOMICS; REVIEW; SKIN FLORA; SKIN FUNCTION; STAPHYLOCOCCUS EPIDERMIDIS; TAXONOMIC IDENTIFICATION; TRANSCRIPTOMICS; ANIMAL; FUNCTIONS OF THE SKIN AND ITS APPENDAGES; MICROBIOLOGY; MICROFLORA; SKIN;

ANIMALS; HUMANS; MICROBIOTA; SKIN; SKIN PHYSIOLOGICAL PHENOMENA;

EID: 84963665108     PISSN: 00223751     EISSN: 14697793     Source Type: Journal    
DOI: 10.1113/JP271638     Document Type: Review

References (125)

1. Alekseyenko AV, Perez-Perez GI, De Souza A, Strober B, Gao Z, Bihan M, Li K, Methé BA & Blaser MJ (2013). Community differentiation of the cutaneous microbiota in psoriasis. Microbiome 1, 31.
2. Ashbee HR & Evans EG (2002). Immunology of diseases associated with Malassezia species. Clin Microbiol Rev 15, 21–57.
3. Athanasopoulos AN, Economopoulou M, Orlova VV, Sobke A, Schneider D, Weber H, Augustin HG, Eming SA, Schubert U, Linn T, Nawroth PP, Hussain M, Hammes HP, Herrmann M, Preissner KT & Chavakis T (2006). The extracellular adherence protein (Eap) of Staphylococcus aureus inhibits wound healing by interfering with host defense and repair mechanisms. Blood 107, 2720–2727.
4. Bastos MC, Ceotto H, Coelho ML & Nascimento JS (2009). Staphylococcal antimicrobial peptides: relevant properties and potential biotechnological applications. Curr Pharm Biotechnol 10, 38–61.
5. Bek-Thomsen M, Lomholt HB, Scavenius C, Enghild JJ & Brüggemann H (2014). Proteome analysis of human sebaceous follicle infundibula extracted from healthy and acne-affected skin. PLoS One 9, e107908.
6. Bertesteanu S, Triaridis S, Stankovic M, Lazar V, Chifiriuc MC, Vlad M & Grigore R (2014). Polymicrobial wound infections: pathophysiology and current therapeutic approaches. Int J Pharm 463, 119–126.
7. Black CE & Costerton JW (2010). Current concepts regarding the effect of wound microbial ecology and biofilms on wound healing. Surg Clin North Am 90, 1147–1160.
8. Bonnar E, Eustace P & Powell FC (1993). The Demodex mite population in rosacea. J Am Acad Dermatol 28, 443–448.
9. Brasch J & Christophers E (1993). Azelaic acid has antimycotic properties in vitro. Dermatology 186, 55–58.
10. Brüggemann H, Henne A, Hoster F, Liesegang H, Wiezer A, Strittmatter A, Hujer S, Dürre P & Gottschalk G (2004). The complete genome sequence of Propionibacterium acnes, a commensal of human skin. Science 305, 671–673.
11. Canesso MC, Vieira AT, Castro TB, Schirmer BG, Cisalpino D, Martins FS, Rachid MA, Nicoli JR, Teixeira MM & Barcelos LS (2014). Skin wound healing is accelerated and scarless in the absence of commensal microbiota. J Immunol 193, 5171–5180.
12. Church D, Elsayed S, Reid O, Winston B & Lindsay R (2006). Burn wound infections. Clin Microbiol Rev 19, 403–434.
13. Clavaud C, Jourdain R, Bar-Hen A, Tichit M, Bouchier C, Pouradier F, El Rawadi C, Guillot J, Ménard-Szczebara F, Breton L, Latgé JP & Mouyna I (2013). Dandruff is associated with disequilibrium in the proportion of the major bacterial and fungal populations colonizing the scalp. PLoS One 8, e58203.
14. Coates R, Moran J & Horsburgh MJ (2014). Staphylococci: colonizers and pathogens of human skin. Future Microbiol 9, 75–91.
15. Cogen AL, Yamasaki K, Sanchez KM, Dorschner RA, Lai Y, MacLeod DT, Torpey JW, Otto M, Nizet V, Kim JE & Gallo RL (2010). Selective antimicrobial action is provided by phenol-soluble modulins derived from Staphylococcus epidermidis, a normal resident of the skin. J Invest Dermatol 130, 192–200.
16. Cohen RJ, Shannon BA, McNeal JE, Shannon T & Garrett KL (2005). Propionibacterium acnes associated with inflammation in radical prostatectomy specimens: a possible link to cancer evolution? J Urol 173, 1969–1974.
17. Costello EK, Lauber CL, Hamady M, Fierer N, Gordon JI & Knight R (2009). Bacterial community variation in human body habitats across space and time. Science 326, 1694–1697.
18. Crosti C, Menni S, Sala F & Piccinno R (1983). Demodectic infestation of the pilosebaceous follicle. J Cutan Pathol 10, 257–261.
19. Dawson TL Jr (2007). Malassezia globosa and restricta: breakthrough understanding of the etiology and treatment of dandruff and seborrheic dermatitis through whole-genome analysis. J Investig Dermatol Symp Proc 12, 15–19.
20. Dekio I, Sakamoto M, Hayashi H, Amagai M, Suematsu M & Benno Y (2007). Characterization of skin microbiota in patients with atopic dermatitis and in normal subjects using 16S rRNA gene-based comprehensive analysis. J Med Microbiol 56, 1675–1683.
21. Dowd SE, Wolcott RD, Sun Y, McKeehan T, Smith E & Rhoads D (2008). Polymicrobial nature of chronic diabetic foot ulcer biofilm infections determined using bacterial tag encoded FLX amplicon pyrosequencing (bTEFAP). PLoS One 3, e3326.
22. Eishi Y, Suga M, Ishige I, Kobayashi D, Yamada T, Takemura T, Takizawa T, Koike M, Kudoh S, Costabel U, Guzman J, Rizzato G, Gambacorta M, du Bois R, Nicholson AG, Sharma OP & Ando M (2002). Quantitative analysis of mycobacterial and propionibacterial DNA in lymph nodes of Japanese and European patients with sarcoidosis. J Clin Microbiol 40, 198–204.
23. Eming SA, Krieg T & Davidson JM (2007). Inflammation in wound repair: molecular and cellular mechanisms. J Invest Dermatol 127, 514–525.
24. Faye T, Holo H, Langsrud T, Nes IF & Brede DA (2011). The unconventional antimicrobial peptides of the classical propionibacteria. Appl Microbiol Biotechnol 89, 549–554.
25. Fierer N, Hamady M, Lauber CL & Knight R (2008). The influence of sex, handedness, and washing on the diversity of hand surface bacteria. Proc Natl Acad Sci USA 105, 17994–17999.
26. Fierer N, Lauber CL, Zhou N, McDonald D, Costello EK & Knight R (2010). Forensic identification using skin bacterial communities. Proc Natl Acad Sci USA 107, 6477–6481.
27. Findley K, Oh J, Yang J, Conlan S, Deming C, Meyer JA, Schoenfeld D, Nomicos E, Park M, NIH Intramural Sequencing Center Comparative Sequencing Program, Kong HH & Segre JA (2013). Topographic diversity of fungal and bacterial communities in human skin. Nature 498, 367–370.
28. Fitz-Gibbon S, Tomida S, Chiu BH, Nguyen L, Du C, Liu M, Elashoff D, Erfe MC, Loncaric A, Kim J, Modlin RL, Miller JF, Sodergren E, Craft N, Weinstock GM & Li H (2013). Propionibacterium acnes strain populations in the human skin microbiome associated with acne. J Invest Dermatol 133, 2152–2160.
29. Flores GE, Bates ST, Knights D, Lauber CL, Stombaugh J, Knight R & Fierer N (2011). Microbial biogeography of public restroom surfaces. PLoS One 6, e28132.
30. Fontana MB, de Bastos MOC & Brandelli A (2006). Bacteriocins Pep5 and epidermin inhibit Staphylococcus epidermidis adhesion to catheters. Curr Microbiol 52, 350–353.
31. Foulongne V, Sauvage V, Hebert C, Dereure O, Cheval J, Gouilh MA, Pariente K, Segondy M, Burguière A, Manuguerra JC, Caro V & Eloit M (2012). Human skin microbiota: high diversity of DNA viruses identified on the human skin by high throughput sequencing. PLoS One 7, e38499.
32. Francis OE, Bendall M, Manimaran S, Hong C, Clement NL, Castro-Nallar E, Snell Q, Schaalje GB, Clement MJ, Crandall KA & Johnson WE (2013). Pathoscope: species identification and strain attribution with unassembled sequencing data. Genome Res 23, 1721–1729.
33. Fujimura S & Nakamura T (1978). Purification and properties of a bacteriocin-like substance (acnecin) of oral Propionibacterium acnes. Antimicrob Agents Chemother 14, 893–898.
34. Gaitanis G, Magiatis P, Hantschke M, Bassukas ID & Velegraki A (2012). The Malassezia genus in skin and systemic diseases. Clin Microbiol Rev 25, 106–141.
35. Gao Z, Tseng CH, Pei Z & Blaser MJ (2007). Molecular analysis of human forearm superficial skin bacterial biota. Proc Natl Acad Sci USA 104, 2927–2932.
36. Gao Z, Tseng CH, Strober BE, Pei Z & Blaser MJ (2008). Substantial alterations of the cutaneous bacterial biota in psoriatic lesions. PLoS One 3, e2719.
37. Gehse M, Höffler U, Gloor M & Pulverer G (1983). Propionibacteria in patients with acne vulgaris and in healthy persons. Arch Dermatol Res 275, 100–104.
38. Gontcharova V, Youn E, Sun Y, Wolcott RD & Dowd SE (2010). A comparison of bacterial composition in diabetic ulcers and contralateral intact skin. Open Microbiol J 4, 8–19.
39. Guéniche A, Knaudt B, Schuck E, Volz T, Bastien P, Martin R, Röcken M, Breton L & Biedermann T (2008). Effects of nonpathogenic gram-negative bacterium Vitreoscilla filiformis lysate on atopic dermatitis: a prospective, randomized, double-blind, placebo-controlled clinical study. Br J Dermatol 159, 1357–1363.
40. Grice EA, Kong HH, Conlan S, Deming CB, Davis J, Young AC, NISC Comparative SequencingProgram, Bouffard GG, Blakesley RW, Murray PR, Green ED, Turner ML & Segre JA (2009). Topographical and temporal diversity of the human skin microbiome. Science 324, 1190–1192.
41. Grice EA & Segre JA (2011). The skin microbiome. Nat Rev Microbiol 9, 244–253.
42. Grice EA, Snitkin ES, Yockey LJ, Bermudez DM, NISC Comparative Sequencing Program, Liechty KW, Segre JA et al. (2010). Longitudinal shift in diabetic wound microbiota correlates with prolonged skin defense response. Proc Natl Acad Sci USA 107, 14799–14804.
43. Hambraeus A (1973). Dispersal and transfer of Staphylococcus aureus in an isolation ward for burned patients. J Hyg (Lond) 71, 787–797.
44. Hamburger M Jr (1947). Transfer of beta hemolytic streptococci by shaking hands. Am J Med 2, 23–25.
45. Heath WR & Carbone FR (2013). The skin-resident and migratory immune system in steady state and memory: innate lymphocytes, dendritic cells and T cells. Nat Immunol 14, 978–985.
46. Hellmark B, Söderquist B, Unemo M & Nilsdotter-Augustinsson Å (2013). Comparison of Staphylococcus epidermidis isolated from prosthetic joint infections and commensal isolates in regard to antibiotic susceptibility, agr type, biofilm production, and epidemiology. Int J Med Microbiol 303, 32–39.
47. Human Microbiome Project Consortium et al. (2012). Structure, function and diversity of the healthy human microbiome. Nature 486, 207–214.
48. Jahns AC, Lundskog B, Ganceviciene R, Palmer RH, Golovleva I, Zouboulis CC, McDowell A, Patrick S & Alexeyev OA (2012). An increased incidence of Propionibacterium acnes biofilms in acne vulgaris: a case–control study. Br J Dermatol 167, 50–58.
49. Javey G, Albini TA & Flynn HW Jr (2010). Resolution of pigmented keratic precipitates following treatment of pseudophakic endophthalmitis caused by Propionibacterium acnes. Ophthalmic Surg Lasers Imaging, 1–3.
50. Kang D, Shi B, Erfe MC, Craft N & Li H (2015). Vitamin B12 modulates the transcriptome of the skin microbiota in acne pathogenesis. Sci Transl Med 7, 293ra103.
51. Kasimatis G, Fitz-Gibbon S, Tomida S, Wong M & Li H (2013). Analysis of complete genomes of Propionibacterium acnes reveals a novel plasmid and increased pseudogenes in an acne associated strain. Biomed Res Int 2013, 918320.
52. Kilian M, Scholz CF & Lomholt HB (2012). Multilocus sequence typing and phylogenetic analysis of Propionibacterium acnes. J Clin Microbiol 50, 1158–1165.
53. Kligman AM & Christensen MS (2011). Demodex folliculorum: requirements for understanding its role in human skin disease. J Invest Dermatol 131, 8–10.
54. Kong HH, Oh J, Deming C, Conlan S, Grice EA, Beatson MA, Nomicos E, Polley EC, Komarow HD, NISC Comparative Sequence Program, Murray PR, Turner ML & Segre JA et al. (2012). Temporal shifts in the skin microbiome associated with disease flares and treatment in children with atopic dermatitis. Genome Res 22, 850–859.
55. Lai Y, Cogen AL, Radek KA, Park HJ, Macleod DT, Leichtle A, Ryan AF, Di Nardo A & Gallo RL (2010). Activation of TLR2 by a small molecule produced by Staphylococcus epidermidis increases antimicrobial defense against bacterial skin infections. J Invest Dermatol 130, 2211–2221.
56. Larson E (2001). Hygiene of the skin: when is clean too clean? Emerg Infect Dis 7, 225–230.
57. Lax S, Smith DP, Hampton-Marcell J, Owens SM, Handley KM, Scott NM, Gibbons SM, Larsen P, Shogan BD, Weiss S, Metcalf JL, Ursell LK, Vázquez-Baeza Y, Van Treuren W, Hasan NA, Gibson MK, Colwell R, Dantas G, Knight R & Gilbert JA (2014). Longitudinal analysis of microbial interaction between humans and the indoor environment. Science 345, 1048–1052.
58. Leeming JP, Holland KT & Bojar RA (1986). The in vitro antimicrobial effect of azelaic acid. Br J Dermatol 115, 551–556.
59. Li M, Lai Y, Villaruz AE, Cha DJ, Sturdevant DE & Otto M (2007). Gram-positive three-component antimicrobial peptide-sensing system. Proc Natl Acad Sci USA 104, 9469–9474.
60. Liu J, Yan R, Zhong Q, Ngo S, Bangayan NJ, Nguyen L, Lui T, Liu M, Erfe MC, Craft N, Tomida S & Li H (2015). The diversity and host interactions of Propionibacterium acnes bacteriophages on human skin. ISME J 9, 2078–2093.
61. Lomholt HB & Kilian M (2010). Population genetic analysis of Propionibacterium acnes identifies a subpopulation and epidemic clones associated with acne. PLoS One 5, e12277.
62. Luo C, Knight R, Siljander H, Knip M, Xavier RJ & Gevers D (2015). ConStrains identifies microbial strains in metagenomic datasets. Nat Biotechnol 33, 1045–1052.
63. Ma Y, Madupu R, Karaoz U, Nossa CW, Yang L, Yooseph S, Yachimski PS, Brodie EL, Nelson KE & Pei Z (2014). Human papillomavirus community in healthy persons, defined by metagenomics analysis of human microbiome project shotgun sequencing data sets. J Virol 88, 4786–4797.
64. McDowell A, Gao A, Barnard E, Fink C, Murray PI, Dowson CG, Nagy I, Lambert PA & Patrick S (2011). A novel multilocus sequence typing scheme for the opportunistic pathogen Propionibacterium acnes and characterization of type I cell surface-associated antigens. Microbiology 157, 1990–2003.
65. McDowell A, Nagy I, Magyari M, Barnard E & Patrick S (2013). The opportunistic pathogen Propionibacterium acnes: insights into typing, human disease, clonal diversification and CAMP factor evolution. PLoS One 8, e70897.
66. McDowell A, Perry AL, Lambert PA & Patrick S (2008). A new phylogenetic group of Propionibacterium acnes. J Med Microbiol 57, 218–224.
67. McDowell A, Valanne S, Ramage G, Tunney MM, Glenn JV, McLorinan GC, Bhatia A, Maisonneuve JF, Lodes M, Persing DH & Patrick S (2005). Propionibacterium acnes types I and II represent phylogenetically distinct groups. J Clin Microbiol 43, 326–334.
68. Madison KC (2003). Barrier function of the skin: ‘la raison d'être’ of the epidermis. J Invest Dermatol 121, 231–241.
69. Mahe YF, Perez MJ, Tacheau C, Fanchon C, Martin R, Rousset F & Seite S (2013). A new Vitreoscilla filiformis extract grown on spa water-enriched medium activates endogenous cutaneous antioxidant and antimicrobial defenses through a potential Toll-like receptor 2/protein kinase C, zeta transduction pathway. Clin Cosmet Investig Dermatol 6, 191–196.
70. Marples RR, McGinley KJ & Mills OH (1973). Microbiology of comedones in acne vulgaris. J Invest Dermatol 60, 80–83.
71. Mathieu A, Delmont TO, Vogel TM, Robe P, Nalin R & Simonet P (2013). Life on human surfaces: skin metagenomics. PLoS One 8, e65288.
72. Meadow JF, Altrichter AE & Green JL (2014a). Mobile phones carry the personal microbiome of their owners. PeerJ 2, e447.
73. Meadow JF, Altrichter AE, Kembel SW, Moriyama M, O'Connor TK, Womack AM, Brown GZ, Green JL & Bohannan BJ (2014b). Bacterial communities on classroom surfaces vary with human contact. Microbiome 2, 7.
74. Meadow JF, Bateman AC, Herkert KM, O'Connor TK & Green JL (2013). Significant changes in the skin microbiome mediated by the sport of roller derby. PeerJ 1, e53.
75. Mendes JJ, Leandro C, Corte-Real S, Barbosa R, Cavaco-Silva P, Melo-Cristino J, Górski A & Garcia M (2013). Wound healing potential of topical bacteriophage therapy on diabetic cutaneous wounds. Wound Repair Regen 21, 595–603.
76. Misic AM, Gardner SE & Grice EA (2014). The wound microbiome: modern approaches to examining the role of microorganisms in impaired chronic wound healing. Adv Wound Care (New Rochelle) 3, 502–510.
77. Murillo N, Aubert J & Raoult D (2014). Microbiota of Demodex mites from rosacea patients and controls. Microb Pathog 71–72, 37–40.
78. Naik S, Bouladoux N, Wilhelm C, Molloy MJ, Salcedo R, Kastenmuller W, Deming C, Quinones M, Koo L, Conlan S, Spencer S, Hall JA, Dzutsev A, Kong H, Campbell DJ, Trinchieri G, Segre JA & Belkaid Y (2012). Compartmentalized control of skin immunity by resident commensals. Science 337, 1115–1119.
79. Nakatsuji T, Tang DC, Zhang L, Gallo RL & Huang CM (2011). Propionibacterium acnes CAMP factor and host acid sphingomyelinase contribute to bacterial virulence: potential targets for inflammatory acne treatment. PLoS One 6, e14797.
80. Nazzaro-Porro M & Passi S (1978). Identification of tyrosinase inhibitors in cultures of Pityrosporum. J Invest Dermatol 71, 205–208.
81. Nobrega FL, Costa AR, Kluskens LD & Azeredo J (2015). Revisiting phage therapy: new applications for old resources. Trends Microbiol 23, 185–191.
82. O'Gara JP & Humphreys H (2001). Staphylococcus epidermidis biofilms: importance and implications. J Med Microbiol 50, 582–587.
83. Oh J, Byrd AL, Deming C, Conlan S, NISC Comparative Sequencing Program, Kong HH & Segre JA et al. (2014). Biogeography and individuality shape function in the human skin metagenome. Nature 514, 59–64.
84. Oh J, Conlan S, Polley EC, Segre JA & Kong HH (2012). Shifts in human skin and nares microbiota of healthy children and adults. Genome Med 4, 77.
85. Paulino LC, Tseng CH & Blaser MJ (2008). Analysis of Malassezia microbiota in healthy superficial human skin and in psoriatic lesions by multiplex real-time PCR. FEMS Yeast Res 8, 460–471.
86. Paulino LC, Tseng CH, Strober BE & Blaser MJ (2006). Molecular analysis of fungal microbiota in samples from healthy human skin and psoriatic lesions. J Clin Microbiol 44, 2933–2941.
87. Percival SL, Emanuel C, Cutting KF & Williams DW (2012). Microbiology of the skin and the role of biofilms in infection. Int Wound J 9, 14–32.
88. Pincus NB, Reckhow JD, Saleem D, Jammeh ML, Datta SK & Myles IA (2015). Strain specific phage treatment for Staphylococcus aureus infection is influenced by host immunity and site of infection. PLoS One 10, e0124280.
89. Pittet D, Dharan S, Touveneau S, Sauvan V & Perneger TV (1999). Bacterial contamination of the hands of hospital staff during routine patient care. Arch Intern Med 159, 821–826.
90. Price LB, Liu CM, Melendez JH, Frankel YM, Engelthaler D, Aziz M, Bowers J, Rattray R, Ravel J, Kingsley C, Keim PS, Lazarus GS & Zenilman JM (2009). Community analysis of chronic wound bacteria using 16S rRNA gene-based pyrosequencing: impact of diabetes and antibiotics on chronic wound microbiota. PLoS One 4, e6462.
91. Ramage G, Tunney MM, Patrick S, Gorman SP & Nixon JR (2003). Formation of Propionibacterium acnes biofilms on orthopaedic biomaterials and their susceptibility to antimicrobials. Biomaterials 24, 3221–3227.
92. Ramsey JP, Mercurio A, Holland JA, Harris RN & Minbiole KP (2015). The cutaneous bacterium Janthinobacterium lividum inhibits the growth of Trichophyton rubrum in vitro. Int J Dermatol 54, 156–159.
93. Robson MC (1997). Wound infection. A failure of wound healing caused by an imbalance of bacteria. Surg Clin North Am 77, 637–650.
94. Rogers KL, Fey PD & Rupp ME (2009). Coagulase-negative staphylococcal infections. Infect Dis Clin North Am 23, 73–98.
95. Rollason J, McDowell A, Albert HB, Barnard E, Worthington T, Hilton AC, Vernallis A, Patrick S, Elliott T & Lambert P (2013). Genotypic and antimicrobial characterisation of Propionibacterium acnes isolates from surgically excised lumbar disc herniations. Biomed Res Int 2013, 530382.
96. Ross JI, Snelling AM, Carnegie E, Coates P, Cunliffe WJ, Bettoli V, Tosti G, Katsambas A, Galvan Peréz Del Pulgar JI, Rollman O, Török L, Eady EA & Cove JH (2003). Antibiotic-resistant acne: lessons from Europe. Br J Dermatol 148, 467–478.
97. Sampedro MF, Piper KE, McDowell A, Patrick S, Mandrekar JN, Rouse MS, Steckelberg JM & Patel R (2009). Species of Propionibacterium and Propionibacterium acnes phylotypes associated with orthopedic implants. Diagn Microbiol Infect Dis 64, 138–145.
98. Sanford JA & Gallo RL (2013). Functions of the skin microbiota in health and disease. Semin Immunol 25, 370–377.
99. Schaeverbeke T, Lequen L, de Barbeyrac B, Labbé L, Bébéar CM, Morrier Y, Bannwarth B, Bébéar C & Dehais J (1998). Propionibacterium acnes isolated from synovial tissue and fluid in a patient with oligoarthritis associated with acne and pustulosis. Arthritis Rheum 41, 1889–1893.
100. Schloissnig S, Arumugam M, Sunagawa S, Mitreva M, Tap J, Zhu A, Waller A, Mende DR, Kultima JR, Martin J, Kota K, Sunyaev SR, Weinstock GM & Bork P (2013). Genomic variation landscape of the human gut microbiome. Nature 493, 45–50.
101. Schloss PD, Iverson KD, Petrosino JF & Schloss SJ (2014). The dynamics of a family's gut microbiota reveal variations on a theme. Microbiome 2, 25.
102. Schmid-Wendtner MH & Korting HC (2006). The pH of the skin surface and its impact on the barrier function. Skin Pharmacol Physiol 19, 296–302.
103. Selander C, Zargari A, Möllby R, Rasool O & Scheynius A (2006). Higher pH level, corresponding to that on the skin of patients with atopic eczema, stimulates the release of Malassezia sympodialis allergens. Allergy 61, 1002–1008.
104. Shu M, Wang Y, Yu J, Kuo S, Coda A, Jiang Y, Gallo RL & Huang CM (2013). Fermentation of Propionibacterium acnes, a commensal bacterium in the human skin microbiome, as skin probiotics against methicillin-resistant Staphylococcus aureus. PLoS One 8, e55380.
105. Singer AJ & Clark RA (1999). Cutaneous wound healing. N Engl J Med 341, 738–746.
106. Song SJ, Lauber C, Costello EK, Lozupone CA, Humphrey G, Berg-Lyons D, Caporaso JG, Knights D, Clemente JC, Nakielny S, Gordon JI, Fierer N & Knight R (2013). Cohabiting family members share microbiota with one another and with their dogs. Elife 2, e00458.
107. Soothill JS (1994). Bacteriophage prevents destruction of skin grafts by Pseudomonas aeruginosa. Burns 20, 209–211.
108. Statnikov A, Alekseyenko AV, Li Z, Henaff M, Perez-Perez GI, Blaser MJ & Aliferis CF (2013). Microbiomic signatures of psoriasis: feasibility and methodology comparison. Sci Rep 3, 2620.
109. Sulakvelidze A, Alavidze Z & Morris JG (2001). Bacteriophage therapy. Antimicrob Agents Chemother 45, 649–659.
110. Tomida S, Nguyen L, Chiu BH, Liu J, Sodergren E, Weinstock GM & Li H (2013). Pan-genome and comparative genome analyses of Propionibacterium acnes reveal its genomic diversity in the healthy and diseased human skin microbiome. MBio 4, e00003–00013.
111. Tragiannidis A, Bisping G, Koehler G & Groll AH (2010). Minireview: Malassezia infections in immunocompromised patients. Mycoses 53, 187–195.
112. Tunney MM, Patrick S, Gorman SP, Nixon JR, Anderson N, Davis RI, Hanna D & Ramage G (1998). Improved detection of infection in hip replacements. A currently underestimated problem. J Bone Joint Surg Br 80, 568–572.
113. Ushijima T, Takahashi M & Ozaki Y (1984). Acetic, propionic, and oleic acid as the possible factors influencing the predominant residence of some species of Propionibacterium and coagulase-negative Staphylococcus on normal human skin. Can J Microbiol 30, 647–652.
114. Valanne S, McDowell A, Ramage G, Tunney MM, Einarsson GG, O'Hagan S, Wisdom GB, Fairley D, Bhatia A, Maisonneuve JF, Lodes M, Persing DH & Patrick S (2005). CAMP factor homologues in Propionibacterium acnes: a new protein family differentially expressed by types I and II. Microbiology 151, 1369–1379.
115. Vieira A, Silva YJ, Cunha A, Gomes NC, Ackermann HW & Almeida A (2012). Phage therapy to control multidrug-resistant Pseudomonas aeruginosa skin infections: in vitro and ex vivo experiments. Eur J Clin Microbiol Infect Dis 31, 3241–3249.
116. Volz T, Skabytska Y, Guenova E, Chen KM, Frick JS, Kirschning CJ, Kaesler S, Röcken M & Biedermann T (2014). Nonpathogenic bacteria alleviating atopic dermatitis inflammation induce IL-10-producing dendritic cells and regulatory Tr1 cells. J Invest Dermatol 134, 96–104.
117. Wang Y, Kuo S, Shu M, Yu J, Huang S, Dai A, Two A, Gallo RL & Huang CM (2014). Staphylococcus epidermidis in the human skin microbiome mediates fermentation to inhibit the growth of Propionibacterium acnes: implications of probiotics in acne vulgaris. Appl Microbiol Biotechnol 98, 411–424.
118. Wanke I, Steffen H, Christ C, Krismer B, Götz F, Peschel A, Schaller M & Schittek B (2011). Skin commensals amplify the innate immune response to pathogens by activation of distinct signaling pathways. J Invest Dermatol 131, 382–390.
119. Wisplinghoff H, Bischoff T, Tallent SM, Seifert H, Wenzel RP & Edmond MB (2004). Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study. Clin Infect Dis 39, 309–317.
120. Wood M, Gibbons SM, Lax S, Eshoo-Anton TW, Owens SM, Kennedy S, Gilbert JA & Hampton-Marcell JT (2015). Athletic equipment microbiota are shaped by interactions with human skin. Microbiome 3, 25.
121. Wylie KM, Mihindukulasuriya KA, Zhou Y, Sodergren E, Storch GA & Weinstock GM (2014). Metagenomic analysis of double-stranded DNA viruses in healthy adults. BMC Biol 12, 71.
122. Xu J, Saunders CW, Hu P, Grant RA, Boekhout T, Kuramae EE, Kronstad JW, Deangelis YM, Reeder NL, Johnstone KR, Leland M, Fieno AM, Begley WM, Sun Y, Lacey MP, Chaudhary T, Keough T, Chu L, Sears R, Yuan B & Dawson TL (2007). Dandruff-associated Malassezia genomes reveal convergent and divergent virulence traits shared with plant and human fungal pathogens. Proc Natl Acad Sci USA 104, 18730–18735.
123. Zhang E, Tanaka T, Tajima M, Tsuboi R, Nishikawa A & Sugita T (2011). Characterization of the skin fungal microbiota in patients with atopic dermatitis and in healthy subjects. Microbiol Immunol 55, 625–632.
124. Zhang M, Jiang Z, Li D, Jiang D, Wu Y, Ren H, Peng H & Lai Y (2015). Oral antibiotic treatment induces skin microbiota dysbiosis and influences wound healing. Microb Ecol 69, 415–421.
125. Zhang YQ, Ren SX, Li HL, Wang YX, Fu G, Yang J, Qin ZQ, Miao YG, Wang WY, Chen RS, Shen Y, Chen Z, Yuan ZH, Zhao GP, Qu D, Danchin A & Wen YM (2003). Genome-based analysis of virulence genes in a non-biofilm-forming Staphylococcus epidermidis strain (ATCC 12228). Mol Microbiol 49, 1577–1593.